Home|Journals|Articles by Year

Directory for Medical Articles
 

Original Research



Clinical Analysis to Elicit the Sadhya-Asadhyata of Prameha in Diagnosed Cases of Type-II Diabetes Mellitus

Konica Gera, Nellufar Siddique, Baldev Kumar.


Abstract

Introduction: Diabetes mellitus is a giant disease considered as one of the arch enemy of the mankind. Looking at its gravity, WHO has taken up a close vigilance and survey about this world over. The number of people with diabetes has risen from 108 millions (1980) to 422 millions (2014). Prameha (DM) (excessive urine in terms of frequency and quantity) is spreading its clutches rapidly due to varied dietary-lifestyle patterns. Diabetes-a course of disease with similar signs and symptoms makes way for its side by side study. In popular practice most of the Ayurvedic physicians prescribe a uniform kind of treatment to all the patients of DM they come across considering it Asadhya (incurable), which is not justified as every diabetic patient may not be Asadhya (Madhumehi) always. Material and Methods: 60 patients of DM-II divided into 3-Groups (20 each) of Kapha (Group-A), Pitta (Group-B) and Vata (Group-C) Prameha (126mg/dl≤FBS≤250mg/dl) were administered a common Sarva-Pramehahara-Yoga for 60 days and the variations in the blood sugar were noted & assessed to predict the Sadhya-Asadhyata of Prameha. Observations and Results: In Group-A, B & C improvement in FBS was 36.44%, 31.73% & 26.62% respectively while improvement in PPBS was noted as 41.34%, 37.83% and 31.78% respectively. As the results obtained were found to be statistically significant (with p

Key words: Bhunimbadi Churna; Diabetes Mellitus; Madhumeha; Prameha; Sadhya-Asadhya






Full-text options


Share this Article



Online Article Submission
• ejmanager.com







eJManager.com
Review(er)s Central
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.